 MASON, Ohio--BUSINESS WIRE--AtriCure, Inc. Nasdaq: ATRC, a leading innovator in treatments for atrial fibrillation Afib and left atrial appendage LAA management, today announced that it will release its fourth quarter and full year 2020 financial results on Tuesday, February 23, 2021. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Tuesday, February 23, 2021 to discuss its fourth quarter and full year 2020 financial results. The call may be accessed through an operator 